Ads
related to: questran warnings for prostate cancer risk- Patient Resources
Download informative brochures for
patients and caregivers.
- Find An Imaging Site
Locate the nearest imaging site
or contact customer service.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- About Us
Understand how a PSMA PET scan may
help with your treatment plan.
- Patient Resources
Search results
Results from the WOW.Com Content Network
Getting regular screenings and check-ups, knowing your risk factors for prostate cancer, and communicating with your doctor can help catch the disease early so you can get treated, Dr. Spratt says ...
[45] [46] Moreover, the lifetime incidence of breast cancer in men is approximately 0.1%, [47] the average age of diagnosis of prostate cancer and male breast cancer are similar (around 70 years), [10] [48] and millions of men have been treated with bicalutamide for prostate cancer, [49] all of which are potentially in support of the notion of ...
Paul L. Nguyen is an American radiation oncologist and researcher specializing in prostate cancer research and clinical care. Nguyen has worked with the Dana–Farber Cancer Institute, the Brigham and Women's Hospital, and Harvard Medical School, and his research has sought to assess the effectivity of hormone-targeted therapy in treating prostate cancer, the importance of social systems like ...
More prostate cancer testing and detection for Black men. Recent research and guidelines from the Prostate Cancer Foundation highlight a significant update in prostate cancer screening for Black ...
Bicalutamide, sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer. [10] It is typically used together with a gonadotropin-releasing hormone (GnRH) analogue or surgical removal of the testicles to treat metastatic prostate cancer (mPC).
Black men in the U.S., Khanna said, are two times more likely to die from prostate cancer than white men. “Not all prostate cancer is lethal, but we have seen that black men do have a higher ...
Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of countries. [91] Prostate cancer is rare in those under 40 years old, [92] and most cases occur in those over 60 years, [2] with the average person diagnosed at 67. [93]
The risk of disease progression and metastasis (spread of the cancer) may be increased, but this increase risk appears to be small if the program of surveillance is followed closely, generally including serial PSA assessments and repeat prostate biopsies every 1–2 years depending on the PSA trends.
Ads
related to: questran warnings for prostate cancer risk